Choline is a full agonist in inducing activation of neuronal nitric oxide synthase via the muscarinic M1 receptor

Pharmacology

Volumn 60, Issue 2, 2000, Pages 82-89

  Carriere, Jason Lee ^a   El Fakahany, Esam E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Calcium signaling; Choline; M1 subtype; Muscarinic acetylcholine receptors; Neuronal nitric oxide synthase

Indexed keywords

CALCIUM ION; CHOLINE; ENZYME ACTIVATOR; MUSCARINIC M1 RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHO CELL; CLONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMENTIA; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0033961335     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028351     Document Type: Article

References (35)

1. Bartus RT, Beer B, Lippa AS: The cholinergic hypothesis of geriatric memory disfunction. Science 1982;217:408-414.
2. McGeer PL: The 12th J.A.F. Stevenson Memorial Lecture: Aging, Alzheimer's disease, and the cholinergic system. Can J Physiol Pharmacol 1984;62:741-754.
3. Fibiger HC: Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence [see comments]. Trends Neurosci 1991;14:220-223.
4. Jerusalinsky D, Kornisiuk E, Izquierdo I: Cholinergic neurotransmission and synaptic plasticity concerning memory processing. Neurochem Res 1997;22:507-515.
5. Pavia J, de Ceballos ML, Sanchez de la Cuesta F: Alzheimer's disease: Relationship between muscarinic cholinergic receptors, β-amyloid and tau proteins. Fundam Clin Pharmacol 1998;12:473-481.
6. McKinney M, Coyle JT: The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease? Mayo Clin Proc 1991;66:1225-1237.
7. Benzi G, Moretti A: Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease? Eur J Pharmacol 1998;346:1-13.
8. Leathwood P, Schlosser B: Phosphatidylcholine, choline and cholinergic function. Int J Vitam Nutr Res 1986;56(suppl 29):49-67.
9. Palacios JM, Kuhar MJ: Choline: Binding studies provide some evidence for a weak, direct agonist action in brain. Mol Pharmacol 1979;16:1084-1088.
10. 3H]-L-QNB binding to muscarinic acetylcholine receptors. Biochem Biophys Res Commun 1983;113:280-285.
11. Speth RC, Yamamura HI: On the ability of choline and its analogues to interact with muscarinic cholinergic receptors in the rat brain. Eur J Pharmacol 1979;58:197-201.
12. Costa LG, Murphy SD: Interaction of choline with nicotinic and muscarinic cholinergic receptors in the rat brain in vitro. Clin Exp Pharmacol Physiol 1984;11:649-654.
13. Alkondon M, Pereira EFR, Cortes WS, Mae-licke A, Albuquerque EX: Choline is a selective agonist of α7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci 1997; 9:2734-2742.
14. 1 muscarinic acetylcholine receptors with double mutations at the junction of TM V1 and the third extracellular domain. J Pharmacol Exp Ther 1998;286:1129-1139.
15. Kilbinger H, Kruel R: Choline inhibits acetylcholine release via presynaptic muscarine receptors. Naunyn Schmiedebergs Arch Pharmacol 1981;316:131-134.
16. Costa LG, Kaylor G, Murphy SD: Interaction of choline with muscarine receptor-stimulated phosphoinositide metabolism in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 1986; 334:536-539.
17. 1 muscarinic receptors stimulate rapid and prolonged phases of neuronal nitric oxide synthase activity: Involvement of different calcium pools. J Neurochem 1998;71: 487-497.
18. Wang SZ, Lee SY, Zhu SZ, El-Fakahany EE: Differential coupling of m1, m3, and m5 muscarinic receptors to activation of neuronal nitric oxide synthase. Pharmacology 1996;53: 271-280.
19. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450.
20. Wang SZ, Zhu SZ, El-Fakahany EE: Efficient coupling of m5 muscarinic acetylcholine receptors to activation of nitric oxide synthasc. J Pharmacol Exp Ther 1994;268:552-557.
21. Nishi S, Soeda H, Koketsu K: Release of acetylcholine from sympathetic preganglionic nerve terminals. J Neurophysiol 1966;30:114-134.
22. 7/3-phth) at cloned muscarinic acetylcholine receptors. Biochem Pharmacol 1999;57:171-179.
23. Ehlert FJ, Roeske WR, Yamamura HI: Molecular biology, pharmacology, and brain distribution of subtypes of the muscarinic receptor; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995, pp 111-123.
24. Huang EP: Synaptic plasticity: A role for nitric oxide in LTP. Curr Biol 1997;7:R141-R143.
25. Kendrick KM, Guevara-Guzman R, Zorrilla J, Hinton MR, Broad KD, Mimmack M, Ohkura S: Formation of olfactory memories mediated by nitric oxide. Nature 1997;388:670-674.
26. Wurtman RJ: Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci 1992;15:117-122.
27. Blusztain JK, Holbrook PG, Lakher M, Liscovitch M, Maire J-C, Mauron C, Richardson I, Tacconi M, Wurtman RJ: 'Autocannibalism' of membrane choline-phospholipids: Physiology and pathology. Psychopharmacol Bull 1986; 22:781-786.
28. Maire J-C, Wurtman RJ: Effects of electrical stimulation and choline availability on the release and contents of acetylcholine and choline in superfused slices from rat striatum. J Physiol Paris 1985;80:189-195.
29. Roth GS, Joseph JA, Mason RP: Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends Neurosci 1995;18:203-206.
30. Ehrenstein G, Galdzicki Z, Lange GD: The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease. Biophys J 1997;73:1276-1280.
31. Bissette G, Seidler FJ, Nemeroff CB, Slotkin TA: High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy. Ann NY Acad Sci 1996;777:197-204.
32. Cacabelos R, Alvarez XA, Franco-Maside A, Fernandez-Novoa L, Caamano J: Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia. Ann NY Acad Sci 1993;695:321-323.
33. Amenta F, Franch F, Ricci A, Vega JA: Cholinergic neurotransmission in the hippocampus of aged rats: Influence of L-α-glycerylphosphoryl-choline treatment. Ann NY Acad Sci 1993;695: 311-313.
34. Agut JG, Coviella IL, Ortiz JA, Wurtman RJ: Oral cytidine 5'-diphosphate choline administration to rats increases brain phospholipid levels. Ann NY Acad Sci 1993;695:318-320.
35. Zeisel SH: Choline: Essential for brain development and function. Adv Pediatr 1997;44:263-294.